Education has been one of the Dermatology Nurses’ Association (DNA) greatest priorities during their nearly 4 decades of existence. This is highlighted in The Dermatology Nurses’ Association 36th Annual Convention that runs from February 14 to 17, 2018, at the Sheraton San Diego Hotel and Marina.
The DNA conferences have always emphasized patient outcomes, evidence-based practice, and networking for an inclusive audience, including dermatologic nurse practitioners (NPs), registered nurses (RNs), licensed practical nurses, medical assistance, and other support staff, as well as other specialties and primary care seeking dermatologic knowledge.
Figure. The Dermatology Nurses’ Association 36th Annual Convention runs from February 14 to 17, 2018, at the Sheraton San Diego Hotel and Marina.
Annual Conference
This year, the DNA focuses on an Evolution theme, recognizing that dermatologic care is ever-changing and that research, discovery, and innovation contribute to continually-improved patient outcomes. By educating dermatology professionals with the most current care guidelines, expert knowledge, new skills, and providing venues for networking, the DNA offers exemplary opportunities for professional development.
Sessions
Educational sessions with high-demand topics including biologics, atopic dermatitis, psoriasis, dermatopathology, dermoscopy, autoimmune disorders, a spotlight on immunology function of the skin, and many other current topics will run concurrently. Comprehensive workshops will also be held, including dermatologic surgery, essentials of dermatology, phototherapy and photodynamic therapy, and cosmetic dermatology. Many opportunities will be available to learn about new products, medications, and therapies, which are rapidly evolving within the dermatology specialty.
The DNA’s core purpose is to promote excellence in dermatologic care, focusing on patient’s well-being, inclusive of their dermatologic health, but not exclusive of their social, financial, and emotional needs. The convention ensures these important factors are considered throughout the educational offerings.
The convention includes several days of exhibits, several hundred attendees, sponsorship opportunities for educational programs, opportunities for volunteerism and mentoring, and the chance for professionals to network in a fun atmosphere with their peers. Additionally, the DNA conventions offers continuing education credits accredited by the American Association of Nurse Practitioners (AANP) and American Nurses Credentialing Center for the sessions and workshops.
Attendees
The meeting is open to those who would like to take advantage of this educational opportunity. Past attendees have included medical assistants, health technicians, licensed practical nurses, licensed vocational nurses, RNs, NPs, physician assistants, doctors, dermatology residents, and office managers.
Student nurses are welcome to attend and have a reduced registration rate. Current DNA members also receive a reduced rate.
Nurse Practitioner Forum
For the experienced or advanced dermatology staff, DNA offers the Nurse Practitioner (NP) Forum that runs concurrently with the annual convention. Although it is specifically geared toward NPs working in dermatology, everyone with an interest in advanced topics and or treatments is welcome to participate in this high-level learning and networking venue.
To provide the content that dermatology professionals want and need, information has been taken from surveys over the past few years and topics that were rated highly or requested most often are included. These include the following:
• Dermatologic issues in immunocompromised patients
• Pediatric dermatology
• Providing care in a complex health care environment
• Skin cancer treatment and prevention
• Autoimmune conditions
• Dermatopathology
NP Forum content will be submitted to the AANP for continuing education and pharmacology credit. For more information about the meeting agenda and to register, please visit https://www.dnanurse.org/dnaeducation/annual-convention/.
Ms Onoday is 2018 Program Planning Committee Chair of The Dermatology Nurses’ Association 36th Annual Convention.
Ms Tofte is 2018 NP Forum Chair of The Dermatology Nurses’ Association 36th Annual Convention.
Education has been one of the Dermatology Nurses’ Association (DNA) greatest priorities during their nearly 4 decades of existence. This is highlighted in The Dermatology Nurses’ Association 36th Annual Convention that runs from February 14 to 17, 2018, at the Sheraton San Diego Hotel and Marina.
The DNA conferences have always emphasized patient outcomes, evidence-based practice, and networking for an inclusive audience, including dermatologic nurse practitioners (NPs), registered nurses (RNs), licensed practical nurses, medical assistance, and other support staff, as well as other specialties and primary care seeking dermatologic knowledge.
Figure. The Dermatology Nurses’ Association 36th Annual Convention runs from February 14 to 17, 2018, at the Sheraton San Diego Hotel and Marina.
Annual Conference
This year, the DNA focuses on an Evolution theme, recognizing that dermatologic care is ever-changing and that research, discovery, and innovation contribute to continually-improved patient outcomes. By educating dermatology professionals with the most current care guidelines, expert knowledge, new skills, and providing venues for networking, the DNA offers exemplary opportunities for professional development.
Sessions
Educational sessions with high-demand topics including biologics, atopic dermatitis, psoriasis, dermatopathology, dermoscopy, autoimmune disorders, a spotlight on immunology function of the skin, and many other current topics will run concurrently. Comprehensive workshops will also be held, including dermatologic surgery, essentials of dermatology, phototherapy and photodynamic therapy, and cosmetic dermatology. Many opportunities will be available to learn about new products, medications, and therapies, which are rapidly evolving within the dermatology specialty.
The DNA’s core purpose is to promote excellence in dermatologic care, focusing on patient’s well-being, inclusive of their dermatologic health, but not exclusive of their social, financial, and emotional needs. The convention ensures these important factors are considered throughout the educational offerings.
The convention includes several days of exhibits, several hundred attendees, sponsorship opportunities for educational programs, opportunities for volunteerism and mentoring, and the chance for professionals to network in a fun atmosphere with their peers. Additionally, the DNA conventions offers continuing education credits accredited by the American Association of Nurse Practitioners (AANP) and American Nurses Credentialing Center for the sessions and workshops.
Attendees
The meeting is open to those who would like to take advantage of this educational opportunity. Past attendees have included medical assistants, health technicians, licensed practical nurses, licensed vocational nurses, RNs, NPs, physician assistants, doctors, dermatology residents, and office managers.
Student nurses are welcome to attend and have a reduced registration rate. Current DNA members also receive a reduced rate.
Nurse Practitioner Forum
For the experienced or advanced dermatology staff, DNA offers the Nurse Practitioner (NP) Forum that runs concurrently with the annual convention. Although it is specifically geared toward NPs working in dermatology, everyone with an interest in advanced topics and or treatments is welcome to participate in this high-level learning and networking venue.
To provide the content that dermatology professionals want and need, information has been taken from surveys over the past few years and topics that were rated highly or requested most often are included. These include the following:
• Dermatologic issues in immunocompromised patients
• Pediatric dermatology
• Providing care in a complex health care environment
• Skin cancer treatment and prevention
• Autoimmune conditions
• Dermatopathology
NP Forum content will be submitted to the AANP for continuing education and pharmacology credit. For more information about the meeting agenda and to register, please visit https://www.dnanurse.org/dnaeducation/annual-convention/.
Ms Onoday is 2018 Program Planning Committee Chair of The Dermatology Nurses’ Association 36th Annual Convention.
Ms Tofte is 2018 NP Forum Chair of The Dermatology Nurses’ Association 36th Annual Convention.
Education has been one of the Dermatology Nurses’ Association (DNA) greatest priorities during their nearly 4 decades of existence. This is highlighted in The Dermatology Nurses’ Association 36th Annual Convention that runs from February 14 to 17, 2018, at the Sheraton San Diego Hotel and Marina.
The DNA conferences have always emphasized patient outcomes, evidence-based practice, and networking for an inclusive audience, including dermatologic nurse practitioners (NPs), registered nurses (RNs), licensed practical nurses, medical assistance, and other support staff, as well as other specialties and primary care seeking dermatologic knowledge.
Figure. The Dermatology Nurses’ Association 36th Annual Convention runs from February 14 to 17, 2018, at the Sheraton San Diego Hotel and Marina.
Annual Conference
This year, the DNA focuses on an Evolution theme, recognizing that dermatologic care is ever-changing and that research, discovery, and innovation contribute to continually-improved patient outcomes. By educating dermatology professionals with the most current care guidelines, expert knowledge, new skills, and providing venues for networking, the DNA offers exemplary opportunities for professional development.
Sessions
Educational sessions with high-demand topics including biologics, atopic dermatitis, psoriasis, dermatopathology, dermoscopy, autoimmune disorders, a spotlight on immunology function of the skin, and many other current topics will run concurrently. Comprehensive workshops will also be held, including dermatologic surgery, essentials of dermatology, phototherapy and photodynamic therapy, and cosmetic dermatology. Many opportunities will be available to learn about new products, medications, and therapies, which are rapidly evolving within the dermatology specialty.
The DNA’s core purpose is to promote excellence in dermatologic care, focusing on patient’s well-being, inclusive of their dermatologic health, but not exclusive of their social, financial, and emotional needs. The convention ensures these important factors are considered throughout the educational offerings.
The convention includes several days of exhibits, several hundred attendees, sponsorship opportunities for educational programs, opportunities for volunteerism and mentoring, and the chance for professionals to network in a fun atmosphere with their peers. Additionally, the DNA conventions offers continuing education credits accredited by the American Association of Nurse Practitioners (AANP) and American Nurses Credentialing Center for the sessions and workshops.
Attendees
The meeting is open to those who would like to take advantage of this educational opportunity. Past attendees have included medical assistants, health technicians, licensed practical nurses, licensed vocational nurses, RNs, NPs, physician assistants, doctors, dermatology residents, and office managers.
Student nurses are welcome to attend and have a reduced registration rate. Current DNA members also receive a reduced rate.
Nurse Practitioner Forum
For the experienced or advanced dermatology staff, DNA offers the Nurse Practitioner (NP) Forum that runs concurrently with the annual convention. Although it is specifically geared toward NPs working in dermatology, everyone with an interest in advanced topics and or treatments is welcome to participate in this high-level learning and networking venue.
To provide the content that dermatology professionals want and need, information has been taken from surveys over the past few years and topics that were rated highly or requested most often are included. These include the following:
• Dermatologic issues in immunocompromised patients
• Pediatric dermatology
• Providing care in a complex health care environment
• Skin cancer treatment and prevention
• Autoimmune conditions
• Dermatopathology
NP Forum content will be submitted to the AANP for continuing education and pharmacology credit. For more information about the meeting agenda and to register, please visit https://www.dnanurse.org/dnaeducation/annual-convention/.
Ms Onoday is 2018 Program Planning Committee Chair of The Dermatology Nurses’ Association 36th Annual Convention.
Ms Tofte is 2018 NP Forum Chair of The Dermatology Nurses’ Association 36th Annual Convention.
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
During the third day of Fall Dermatology Week, James Del Rosso, DO, FAOCD, reviewed antibiotics, both topical and systemic, that are frequently prescribed in dermatology.
During the third day of Fall Dermatology Week, James Del Rosso, DO, FAOCD, reviewed antibiotics, both topical and systemic, that are frequently prescribed in dermatology.
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
